Illumina Supports Israel's National Program to Accelerate Diagnoses of Critically-Ill Newborns with Suspected Genetic DiseasePRNewsWire • 10/27/21
Illumina to Announce Third Quarter 2021 Financial Results on Thursday, November 4, 2021PRNewsWire • 10/13/21
Randomized trial demonstrates whole-genome sequencing leads to precision care for critically ill infantsPRNewsWire • 09/27/21
Illumina, Inc. (ILMN) CEO Francis deSouza Presents at Morgan Stanley 19th Annual Global Healthcare Conference (Transcript)Seeking Alpha • 09/13/21
Illumina, Merck Join Hands For Homologous Recombination Deficiency CDx, Research AssayBenzinga • 09/07/21
Illumina Partners with Merck to Develop and Commercialize Companion Diagnostic and Research Tests for Use in Identifying Specific Cancer MutationsPRNewsWire • 09/07/21